The great majority of the neutron scattering experiments performed by the L&SM group took advantage of the large scale facility including the high-flux reactor of the Institute Laue-Langevin (ILL) in Grenoble, France.
Past experiments largely employed an instrument for Neutron Brillouin Scattering constructed at the ILL by the Italian scientific community in collaboration with Germany. BRISP (BRIllouin SPectrometer) was designed to access low ranges of wavevector transfer Q (approximately between 3 and 16 nm-1) with rather high (80 meV) energy neutrons. Such a condition was achieved by detecting the scattered neutrons at very low scattering angles around the direct beam by means of a two-dimensional 3He-based gas Position Sensitive Detector. The probed dynamical range is the most interesting in studies of the collective dynamics ("pseudo-phonons") of liquids, to which the use of BRISP gave a considerable contribution.
Samples such as liquid metals, hydrogen-bonded liquids, and quantum liquids have been successfully investigated over the years. The kinematic range (Q,E) accessed by various techniques can be analysed in the figure aside, where the extended blue zone is the one covered by specific neutron techniques. The one probed by BRISP is indicated in red.
BRISP @ ILL
IN13 @ ILL
Many instruments at ILL (see www.ill.eu for details) are appropriate for condensed matter studies. Among these, another Italian-French instrument (IN13) has been extensively used with success and important publications by the international neutron community. IN13 is a back-scattering thermal neutron spectrometer designed to perform quasi-elastic scattering experiments aimed at the determination of diffusion processes in liquids and soft matter (see https://www.ill.eu/users/instruments/instruments-list/in13/description/inside-in13). Rather recently IN13 was employed also by our group to characterize an innovative vaccine against breast cancer (Amedeo Amedei et al., “A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer”, I-Science 23, 101250 (2020)).